Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Soluble yeast beta-1,3/1,6-glucan

EU orphan designation number: EU/3/05/294   
Active ingredient: Soluble yeast beta-1,3/1,6-glucan
Indication: Prevention of oral mucositis in head and neck cancer patients undergoing radiation therapy
Sponsor: Biotec Pharmacon ASA
Strandgata 3, 9008 Tromso, Norge

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/06/2005 Orphan designation EMEA/OD/005/05 (2005)1882 of 16/06/2005